Published in Eur J Biochem on May 15, 1995
alpha-Latrotoxin and its receptors. Handb Exp Pharmacol (2008) 1.14
Ca2+-independent insulin exocytosis induced by alpha-latrotoxin requires latrophilin, a G protein-coupled receptor. EMBO J (1998) 0.96
Molecular evolution of α-latrotoxin, the exceptionally potent vertebrate neurotoxin in black widow spider venom. Mol Biol Evol (2013) 0.91
Insecticidal toxins from black widow spider venom. Toxicon (2006) 0.91
Dramatic expansion of the black widow toxin arsenal uncovered by multi-tissue transcriptomics and venom proteomics. BMC Genomics (2014) 0.89
Penelope's web: using alpha-latrotoxin to untangle the mysteries of exocytosis. J Neurochem (2009) 0.89
Recruitment and diversification of an ecdysozoan family of neuropeptide hormones for black widow spider venom expression. Gene (2013) 0.83
Extraction of venom and venom gland microdissections from spiders for proteomic and transcriptomic analyses. J Vis Exp (2014) 0.75
Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A (1993) 2.95
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child (2004) 2.54
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol (2001) 1.65
Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg (2006) 1.63
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol (2000) 1.58
Variations in sulfhydryl, disulfide, and protein content during synchronous and asynchronous growth of HeLa cells. Biophys J (1969) 1.54
Exploiting recombination in single bacteria to make large phage antibody libraries. Nat Biotechnol (2000) 1.53
An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene (1997) 1.50
The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J Neurochem (2000) 1.33
Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci (1998) 1.32
Purification and characterization of a scorpion defensin, a 4kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins. Biochem Biophys Res Commun (1993) 1.29
Extensive lipidation of a Torpedo cysteine string protein. J Biol Chem (1994) 1.29
Spontaneous pneumopericardium, pneumomediastinum and subcutaneous emphysema: unusual complications of asthma in a 2-year-old boy. Emerg Med J (2006) 1.27
Two additional common subunits, ABC10 alpha and ABC10 beta, are shared by yeast RNA polymerases. J Biol Chem (1991) 1.27
TFC3: gene encoding the B-block binding subunit of the yeast transcription factor IIIC. Proc Natl Acad Sci U S A (1992) 1.26
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens (2007) 1.23
Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett (2001) 1.22
A definitive set of oligonucleotide primers for amplifying human V regions. Immunotechnology (1998) 1.18
Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol (2008) 1.17
The CD1 system. Tissue Antigens (1991) 1.16
Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg (1996) 1.06
Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. Int J Parasitol (2001) 1.04
An antibody to a synthetic peptide that recognises SV40 small-t antigen. EMBO J (1982) 1.03
Measuring the impact of venous leg ulcers on quality of life. J Wound Care (2005) 1.03
Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett (1993) 1.02
The association of three subunits with yeast RNA polymerase is stabilized by A14. J Biol Chem (1995) 1.02
Expression and distribution of notch protein members in human placenta throughout pregnancy. Placenta (2006) 1.01
Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proc Natl Acad Sci U S A (1991) 1.00
Black widow spider toxin-induced calcium fluxes and transmitter release in a neurosecretory cell line. Nature (1980) 1.00
Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett (2001) 1.00
A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity. Eur J Biochem (1997) 0.99
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J Immunol Methods (2001) 0.99
Pattern of expression of cyclin D1/CDK4 complex in human placenta during gestation. Cell Tissue Res (2004) 0.99
Low expression of the ClC-2 chloride channel during postnatal development: a mechanism for the paradoxical depolarizing action of GABA and glycine in the hippocampus. Proc Biol Sci (1999) 0.98
A protein induced by NGF in PC12 cells is stored in secretory vesicles and released through the regulated pathway. EMBO J (1989) 0.96
Ca2+-independent insulin exocytosis induced by alpha-latrotoxin requires latrophilin, a G protein-coupled receptor. EMBO J (1998) 0.96
Development of a novel rapid non-invasive screening test for coeliac disease. Gut (2000) 0.95
Directional bias in the perception of translating patterns. Perception (1993) 0.95
Gene expression analysis in calcific tendinopathy of the rotator cuff. Eur Cell Mater (2011) 0.95
A reliable screening procedure for coeliac disease in clinical practice. Scand J Gastroenterol (2002) 0.94
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors. Infect Immun (1999) 0.94
Phage display of Bacillus thuringiensis CryIA(a) insecticidal toxin. FEBS Lett (1997) 0.94
Cysteine string protein immunoreactivity in the nervous system and adrenal gland of rat. J Neurosci (1995) 0.93
Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann Surg Oncol (2008) 0.93
Targeting vectors for intracellular immunisation. Gene (1997) 0.92
Expression of a specific neuronal protein, 14-3-2, during in vitro differentiation of neuroblastoma cells. Exp Cell Res (1980) 0.92
Preparation and properties of the brain specific protein 14-3-2. Brain Res (1977) 0.91
Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther (2006) 0.91
Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts. Acta Endocrinol (Copenh) (1984) 0.91
Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis (2004) 0.90
[Diagnostic imaging of idiopathic synovial osteochondromatosis]. Radiol Med (1995) 0.90
Physical therapy in Parkinson's disease: an open long-term rehabilitation trial. J Neurol (2004) 0.89
Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer (2004) 0.89
Electrical and optical monitoring of alpha-latrotoxin action at Drosophila neuromuscular junctions. Neuroscience (1998) 0.88
Cysteine-string proteins as templates for membrane fusion: models of synaptic vesicle exocytosis. J Theor Biol (1995) 0.88
Refolding of reduced short neurotoxins: circular dichroism analysis. Biochemistry (1980) 0.88
The rabbit CD1 and the evolutionary conservation of the CD1 gene family. Immunogenetics (1989) 0.88
Delineation of the functional site of a snake venom cardiotoxin: preparation, structure, and function of monoacetylated derivatives. Biochemistry (1990) 0.88
Characterization of alpha-latrotoxin interaction with rat brain synaptosomes and PC12 cells. Toxicon (1982) 0.88
Focal nodular hyperplasia-like areas in cirrhosis. Histopathology (2003) 0.88
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients. Dig Liver Dis (2006) 0.87
Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies. Eur J Haematol (2006) 0.85
Structural implications on the interaction of scorpion alpha-like toxins with the sodium channel receptor site inferred from toxin iodination and pH-dependent binding. J Neurochem (2000) 0.85
Rigid spine syndrome. Some evidence of varying pathological patterns. Helv Paediatr Acta (1983) 0.85
ABC of arterial and venous disease: Acute limb ischaemia. BMJ (2000) 0.85
Leiomyoma of the female urethra. A case report and review. Clin Exp Obstet Gynecol (1995) 0.85
Localization of 14-3-2 protein in the rat brain by immunoelectron microscopy. Brain Res (1977) 0.84
Preparation and properties of a neurotoxin purified from the venom of black widow spider (Latrodectus mactans tredecimguttatus). Biochim Biophys Acta (1976) 0.84
Mucinous cystadenoma of the retroperitoneum. A case report and review. Eur J Gynaecol Oncol (1995) 0.83
Strategies to improve the effectiveness of abdominal aortic aneurysm screening programmes. J Med Screen (2004) 0.83
[Liver rupture in HELLP syndrome. Report of a case]. Minerva Chir (2000) 0.83
Cloning and expression of an anti-nerve growth factor (NGF) antibody for studies using the neuroantibody approach. Cell Mol Neurobiol (1993) 0.83
Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol (2007) 0.83
Biochemical characterization and nuclear magnetic resonance structure of novel alpha-conotoxins isolated from the venom of Conus consors. Biochemistry (1999) 0.83
Clearance kinetics of hepatitis C virus under different antiviral therapies. J Med Virol (2001) 0.83
Treatment of urinary incontinence in cystic fibrosis. J Cyst Fibros (2003) 0.83
ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. Eur J Biochem (2001) 0.82
A new omega-conotoxin that targets N-type voltage-sensitive calcium channels with unusual specificity. Biochemistry (2001) 0.82
Cysteine string proteins and presynaptic function. J Physiol Paris (1995) 0.82
Indication of a deeply bound and compact K- pp state formed in the pp- -> pLambdaK+ reaction at 2.85 GeV. Phys Rev Lett (2010) 0.82
A toxin purified from the venom of black widow spider affects the uptake and release of radioactive gamma-amino butyrate and N-epinephrine from rat brain synaptosomes. Eur J Biochem (1979) 0.82
Disposition of sumatriptan in laboratory animals and humans. Drug Metab Dispos (1993) 0.82
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. Br J Dermatol (2004) 0.82
A new conotoxin isolated from Conus consors venom acting selectively on axons and motor nerve terminals through a Na+-dependent mechanism. Eur J Neurosci (1999) 0.81
A diversified family of 12-kDa proteins with a high amino acid sequence similarity to macrophage migration-inhibitory factor (MIF). Eur J Biochem (1994) 0.81
The use of the RACE method to clone hybridoma cDNA when V region primers fail. J Immunol Methods (1994) 0.81
Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system. Proc Natl Acad Sci U S A (1991) 0.81
Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy. Maturitas (1982) 0.81
Changes in the concentration of the brain specific protein 14-3-2, during the development of the superior cervical ganglion of the rat and effects of surgical decentralization. Brain Res (1975) 0.81
Synthesis of charybdotoxin and of two N-terminal truncated analogues. Structural and functional characterisation. Eur J Biochem (1993) 0.81
Mapping the C terminal epitope of the Alzheimer's disease specific antibody MN423. J Immunol Methods (2002) 0.81
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain. Gene (1997) 0.81
Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects. Br J Clin Pharmacol (1987) 0.81
Nutritional surveillance in Tuscany: maternal perception of nutritional status of 8-9 y-old school-children. J Prev Med Hyg (2006) 0.81
Purification of guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes. J Cell Biochem (1998) 0.80
Mathematical model for evaluating the Krebs cycle flux with non-constant glutamate-pool size by 13C-NMR spectroscopy. Evidence for the existence of two types of Krebs cycles in cells. Eur J Biochem (1996) 0.80
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries. Hum Antibodies (2000) 0.80